2011•Linchuang gandanbing zazhiRequires access

Observation upon curative effect of lamivudine and adefovir combination therapy on patients with chronic hepatitis B

Shi Cuife

Open publisher page 0 citations

Abstract

Objective To observe the effect of lamivudine and adefovir combination therapy on patients with chronic hepatitis B.Methods 11 patients tolerated lamivudine switched to adefovir,6 tolerated to adefovir switched to lamivudine,and 28 tolerated lamivudine and 9 tolerated adefovir switched to lamivudine and adefovir combination therapy.Results At the end of 48 weeks therapy,the serum HBV DNA negative rate(76%)and ALT normalization rate(92%)in combination group were much higher than in adefovir(45%,73%)or lamivudine(50%,83%)groups.Conclusion The combination of lamivudine and adefovir therapy is an alternative option in hepatitis B patients tolerated to adefovir or lamivudine.

About this research paper

What this paper is about

Objective To observe the effect of lamivudine and adefovir combination therapy on patients with chronic hepatitis B.Methods 11 patients tolerated lamivudine switched to adefovir,6 tolerated to adefovir switched to lamivudine,and 28 tolerated lamivudine and 9 tolerated adefovir switched to lamivudine and adefovir combination therapy.Results At the end of 48 weeks therapy,the serum HBV DNA negative rate(76%)and ALT normalization rate(92%)in combination group were much higher than in adefovir(45%,73%)or lamivudine(50%,83%)groups.Conclusion The combination of lamivudine and adefovir therapy is an alternative option in hepatitis B patients tolerated to adefovir or lamivudine.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the effect of lamivudine and adefovir combination therapy on patients with chronic hepatitis B.Methods 11 patients tolerated lamivudine switched to adefovir,6 tolerated to adefovir switched to lamivudine,and 28 tolerated lamivudine and 9 tolerated adefovir switched to lamivudine and adefovir combination therapy.Results At the end of 48 weeks therapy,the serum HBV DNA negative rate(76%)and ALT normalization rate(92%)in combination group were much higher than in adefovir(45%,73%)or lamivudine(50%,83%)groups.Conclusion The combination of lamivudine and adefovir therapy is an alternative option in hepatitis B patients tolerated to adefovir or lamivudine.

Key concepts: Adefovir, Lamivudine, Medicine, Chronic hepatitis, Gastroenterology, Hepatitis B, Combination therapy, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Observation upon curative effect of lamivudine and adefovir combination therapy on patients with chronic hepatitis B — Research Paper | ScholarLens